Paracetamol potentiates isaxonine toxicity in vitro

Area of Science:

• Hepatotoxicity and drug interaction studies.
• In vitro toxicology.
• Biochemical pharmacology.

Background:

• Isaxonine is a drug used in neurological treatments.
• Paracetamol is a common analgesic and antipyretic agent known to deplete glutathione.
• Understanding drug-induced liver injury is crucial for patient safety.

Purpose of the Study:

• To evaluate the in vitro toxicity of isaxonine.
• To assess the combined toxicity of isaxonine and paracetamol in rat hepatocytes.
• To investigate potential mechanisms of potentiation.

Main Methods:

• Primary rat hepatocyte cultures were used for in vitro testing.
• Morphometric parameters were measured to assess cell damage.
• Lactate dehydrogenase leakage into the medium quantified cytotoxicity.

Main Results:

• Isaxonine showed no cytotoxicity up to 10(-3) M.
• Paracetamol induced cytotoxicity at concentrations above 0.6 x 10(-3) M.
• Non-cytotoxic concentrations of isaxonine potentiated paracetamol-induced cytotoxicity.

Conclusions:

• Isaxonine exhibits no direct cytotoxic effects on hepatocytes.
• Co-administration of isaxonine significantly enhances paracetamol toxicity.
• The potentiation may involve glutathione depletion, requiring further investigation.